New York Ventures is dedicated to encouraging innovation and fueling economic growth in communities across the State. This venture capital investment arm of Empire State Development is one of New York State's business resources and innovation investments, including the Governor's START-UP NY program, Innovation Hot Spots, the Regional Economic Development Councils, the Centers of Advanced Technology and Centers of Excellence networks, and the SUNY 2020 Initiative.
ZetaGen Therapeutics Inc is a preclinical regenerative medicine company focused on developing innovative products for bone regeneration. Founded in 2015 and based in Syracuse, New York, the company utilizes a small molecule-based osteoinductive platform that targets a novel molecular pathway to create solutions for bone-related injuries, procedures, and diseases. ZetaGen's technology aims to halt cancer progression, alleviate pain, and promote bone healing, thereby improving treatment outcomes for patients and healthcare providers alike. By combining drug and device elements, the company aspires to transform the landscape of bone regeneration therapies.
Envisagenics
Series A in 2023
Envisagenics, Inc. is a biotechnology company founded in 2013 and headquartered in Huntington, New York. It specializes in the development of a predictive analytics platform aimed at accelerating the discovery of RNA therapeutics. The company leverages advanced artificial intelligence and machine learning algorithms to analyze transcriptomic data, helping researchers identify and validate potential drug targets. Envisagenics' flagship technology, SpliceCore, is a cloud-based platform that utilizes RNA splicing analytics to predict drug targets and biomarkers, addressing the complexities of biomedical data. Given that over 30 million people in the U.S. suffer from genetic diseases or cancers related to RNA splicing errors, the company's mission is to streamline the development of innovative therapeutic solutions. By providing an in-silico RNA therapeutics discovery platform, Envisagenics enhances the efficiency of drug development processes, reducing time, cost, and risk associated with bringing new therapies to market through partnerships with biopharmaceutical companies.
C16 Biosciences
Series A in 2023
C16 Biosciences, Inc. is a biotechnology company based in New York, established in 2017, specializing in the production of sustainable alternatives to palm oil through microbiology and fermentation processes. The firm focuses on creating innovative ingredients for food manufacturers, refiners, and consumers, aiming to decarbonize the supply chains of consumer product brands. C16 Biosciences has developed the Palmless™ platform, which features its first biodesigned ingredient, Torula oil—a premium bioactive oil known for its clinically proven benefits for skin and hair health. By leveraging biomanufacturing techniques, the company provides scalable and sustainable options, addressing the demand for environmentally friendly alternatives in the oil and fat market.
Ursa Space Systems
Series B in 2023
Ursa Space Systems Inc. is a geospatial services company that provides aerial and space-based data products to enhance geographic mapping and location-based information. Its offerings include imagery and information products that support market and weather forecasting, agricultural yield improvement, disaster response, and military intelligence. The company is known for its Ursa Global Oil Storage Monitoring solution, which provides insights into global oil storage for hedge funds, commodities traders, banks, and oil companies. Ursa Space Systems serves various sectors, including precision agriculture, business intelligence, weather monitoring, humanitarian relief, civil protection, mapping, and traffic applications. Founded in 2014, the company is headquartered in Ithaca, New York, and leverages radar satellite data to deliver timely reports, fostering transparency in global markets for the finance and energy industries.
BlocPower
Series B in 2023
BlocPower is an energy technology startup based in Los Angeles, California, focused on creating healthier, greener, and smarter buildings. Founded in 2014 in Brooklyn, New York, by Donnel Baird and Morris Cox, the company specializes in retrofitting urban buildings with advanced energy efficiency technologies and green heating and cooling systems. BlocPower identifies energy-wasting buildings and utilizes a proprietary machine learning platform to determine the most effective retrofits for maximizing energy savings. The company connects various stakeholders, including government agencies, utilities, building owners, and equipment providers, to facilitate these upgrades. With a mission to serve financially underserved communities, BlocPower has completed projects in nearly 1,000 buildings, helping customers save 20–40% on their annual energy bills. By leveraging data and innovative financing, BlocPower aims to reduce carbon emissions and improve health outcomes while addressing the climate crisis.
Juno Medical
Series A in 2022
Juno Care is a whole-family healthcare platform that provides modern open-access care for the entire family’s day-to-day needs, including pediatrics, women’s health, adult primary care, and same-day services. The company was founded in 2020 and is based in New York, New York, United States.
Exostellar
Series A in 2022
Exostellar is a company that specializes in cloud resource management and optimization, helping enterprises reduce their cloud computing expenses. Founded in 2018 and based in Ithaca, New York, Exostellar leverages exclusive patent-pending technologies developed at Cornell University, integrating artificial intelligence and machine learning to enhance its offerings. Its platform includes tools like X-Spot, which dynamically relocates containers between spot and regular instances, and X-Consolidate, which efficiently manages container workloads by consolidating them during low demand and expanding them when necessary. By combining application containers with virtual machines, Exostellar provides a portable architecture that supports live migration of stateful workloads, ultimately improving reliability and performance while driving cost efficiency in cloud computing.
ZetaGen Therapeutics
Series B in 2022
ZetaGen Therapeutics Inc is a preclinical regenerative medicine company focused on developing innovative products for bone regeneration. Founded in 2015 and based in Syracuse, New York, the company utilizes a small molecule-based osteoinductive platform that targets a novel molecular pathway to create solutions for bone-related injuries, procedures, and diseases. ZetaGen's technology aims to halt cancer progression, alleviate pain, and promote bone healing, thereby improving treatment outcomes for patients and healthcare providers alike. By combining drug and device elements, the company aspires to transform the landscape of bone regeneration therapies.
Qunnect
Series A in 2022
Qunnect, LLC specializes in developing modular light-based devices that facilitate the transmission, storage, and reception of encrypted information, aimed at creating large-area ultra-secure networks. Utilizing principles of quantum physics, these devices ensure that any attempt to observe the data alerts both the sender and recipient, thereby enhancing cybersecurity. Founded in 2017 and based in Stony Brook, New York, Qunnect emerged as a spin-off from the Quantum Information Technology group at Stony Brook University. The company's focus is on engineering advanced quantum memories and sources, which are crucial for future information networks and quantum computing. Additionally, Qunnect offers field-deployable hardware systems for optical and long-distance communication, along with an AI-enabled software suite that allows for real-time monitoring of network components. This innovative approach positions Qunnect at the forefront of evolving cyber-security markets by enabling sophisticated and scalable quantum-secure communication solutions.
BlocPower
Series A in 2022
BlocPower is an energy technology startup based in Los Angeles, California, focused on creating healthier, greener, and smarter buildings. Founded in 2014 in Brooklyn, New York, by Donnel Baird and Morris Cox, the company specializes in retrofitting urban buildings with advanced energy efficiency technologies and green heating and cooling systems. BlocPower identifies energy-wasting buildings and utilizes a proprietary machine learning platform to determine the most effective retrofits for maximizing energy savings. The company connects various stakeholders, including government agencies, utilities, building owners, and equipment providers, to facilitate these upgrades. With a mission to serve financially underserved communities, BlocPower has completed projects in nearly 1,000 buildings, helping customers save 20–40% on their annual energy bills. By leveraging data and innovative financing, BlocPower aims to reduce carbon emissions and improve health outcomes while addressing the climate crisis.
GDI
Series A in 2022
GDI, founded in 2009 and based in Rochester, New York, specializes in the development and manufacture of silicon anodes for lithium-ion batteries. The company focuses on creating patented silicon battery materials that provide superior performance compared to traditional lithium-ion and emerging solid-state batteries. These materials are designed for compatibility with various lithium battery architectures and are engineered for mass production, allowing industries to enhance their product development capabilities. GDI's innovations aim to improve battery performance, particularly in terms of charging times, thereby contributing to a more sustainable and efficient energy future.
Ellevest
Series B in 2022
Ellevest, Inc. is an investment management firm founded in 2014 and based in New York City, focusing primarily on providing financial services to women. The firm manages customized client portfolios across various asset classes globally, employing fundamental analysis and a top-down approach in its investment strategy. Ellevest has developed a digital investment platform that offers a personalized experience, utilizing proprietary algorithms tailored to women's financial needs, including salary peaks and goal-specific portfolios. This platform aims to empower female investors by helping them take control of their investments and achieve their financial goals through a user-friendly interface and thoughtful portfolio construction.
The Cru
Seed Round in 2022
The Cru Inc. is a New York-based company established in 2018 that offers a networking platform specifically designed for women. It provides peer coaching services aimed at facilitating personal and professional development. By creating a supportive environment where like-minded individuals can collaborate, The Cru enables women to connect, share experiences, and help one another achieve their goals. The platform simplifies the networking process, allowing users to focus on their growth and advancement.
BlocPower
Venture Round in 2022
BlocPower is an energy technology startup based in Los Angeles, California, focused on creating healthier, greener, and smarter buildings. Founded in 2014 in Brooklyn, New York, by Donnel Baird and Morris Cox, the company specializes in retrofitting urban buildings with advanced energy efficiency technologies and green heating and cooling systems. BlocPower identifies energy-wasting buildings and utilizes a proprietary machine learning platform to determine the most effective retrofits for maximizing energy savings. The company connects various stakeholders, including government agencies, utilities, building owners, and equipment providers, to facilitate these upgrades. With a mission to serve financially underserved communities, BlocPower has completed projects in nearly 1,000 buildings, helping customers save 20–40% on their annual energy bills. By leveraging data and innovative financing, BlocPower aims to reduce carbon emissions and improve health outcomes while addressing the climate crisis.
Kangarootime
Series A in 2022
Kangarootime, Inc. is a company that specializes in providing a cloud-based childcare management solution aimed at connecting parents with childcare professionals. Founded in 2015 and headquartered in Buffalo, New York, Kangarootime offers a comprehensive platform that includes features such as revenue cycle management, mobile and laptop accessibility, enrollment processes, and automated check-in and check-out functionalities. Its services enhance communication and compliance for childcare centers by enabling features like messaging, picture sharing, and employee management. By streamlining operations and improving the connection between care centers and families, Kangarootime empowers childcare providers to scale their operations and adapt in a digital environment.
ENB Therapeutics
Series A in 2022
ENB Therapeutics is a biopharmaceutical company focused on developing small molecule inhibitors aimed at treating melanoma and other cancers. Founded in 2015 and headquartered in New York, the company’s lead product, ENB-001, is a selective endothelin B receptor (ETBR) inhibitor. This innovative therapy has shown promise in preclinical studies to reduce tumor growth and enhance survival rates in cancer models by restoring T-cell infiltration into tumors and inhibiting metastasis. ENB-001 has received Orphan Drug Designation from the FDA, ensuring market exclusivity and strong intellectual property protection. The company is also developing a companion diagnostic to identify patients with over-expressed ETBR pathways, which may allow for expansion into multiple tumor types. By addressing drug resistance commonly seen in cancer patients, ENB Therapeutics aims to establish new standards of care that enhance the effectiveness of existing immunotherapy treatments and improve patient outcomes.
Wesper
Seed Round in 2021
Wesper, formerly known as Tatch Inc., is a company that specializes in the development of a wireless sleep diagnostic patch designed to enhance sleep medicine. Incorporated in 2017 and based in New York, the company utilizes advanced flexible electronics, machine learning, and wearable technology to provide comprehensive sleep analysis in a comfortable setting. The patch monitors various physiological parameters, including respiratory effort, oxygen levels, heart rate, body position, movement, and snoring. This technology allows for the diagnosis of sleep disorders such as sleep apnea, restless leg syndrome, and insomnia, enabling both patients and healthcare providers to gain valuable insights into sleep quality and health.
Envisagenics
Series A in 2021
Envisagenics, Inc. is a biotechnology company founded in 2013 and headquartered in Huntington, New York. It specializes in the development of a predictive analytics platform aimed at accelerating the discovery of RNA therapeutics. The company leverages advanced artificial intelligence and machine learning algorithms to analyze transcriptomic data, helping researchers identify and validate potential drug targets. Envisagenics' flagship technology, SpliceCore, is a cloud-based platform that utilizes RNA splicing analytics to predict drug targets and biomarkers, addressing the complexities of biomedical data. Given that over 30 million people in the U.S. suffer from genetic diseases or cancers related to RNA splicing errors, the company's mission is to streamline the development of innovative therapeutic solutions. By providing an in-silico RNA therapeutics discovery platform, Envisagenics enhances the efficiency of drug development processes, reducing time, cost, and risk associated with bringing new therapies to market through partnerships with biopharmaceutical companies.
REDIST
Seed Round in 2021
A platform making it easy for real estate professionals to find and use the more than $100b in annual real estate incentives; saving time and money on deals. Our current geographic coverage is New York, New Jersey, Connecticut, Massachusetts, Pennsylvania, Florida, Washington D.C. and Virginia. We are located at the Columbia Startup Lab, are currently in Lowenstein Sandler's VentureCrush FG as well as Shadow Ventures Incubator and have recently completed Accelerate 2020 with Bowery Capital and Silicon Valley Bank.
REDIST
Series A in 2021
A platform making it easy for real estate professionals to find and use the more than $100b in annual real estate incentives; saving time and money on deals. Our current geographic coverage is New York, New Jersey, Connecticut, Massachusetts, Pennsylvania, Florida, Washington D.C. and Virginia. We are located at the Columbia Startup Lab, are currently in Lowenstein Sandler's VentureCrush FG as well as Shadow Ventures Incubator and have recently completed Accelerate 2020 with Bowery Capital and Silicon Valley Bank.
BlocPower
Series A in 2021
BlocPower is an energy technology startup based in Los Angeles, California, focused on creating healthier, greener, and smarter buildings. Founded in 2014 in Brooklyn, New York, by Donnel Baird and Morris Cox, the company specializes in retrofitting urban buildings with advanced energy efficiency technologies and green heating and cooling systems. BlocPower identifies energy-wasting buildings and utilizes a proprietary machine learning platform to determine the most effective retrofits for maximizing energy savings. The company connects various stakeholders, including government agencies, utilities, building owners, and equipment providers, to facilitate these upgrades. With a mission to serve financially underserved communities, BlocPower has completed projects in nearly 1,000 buildings, helping customers save 20–40% on their annual energy bills. By leveraging data and innovative financing, BlocPower aims to reduce carbon emissions and improve health outcomes while addressing the climate crisis.
Ursa Space Systems
Series B in 2021
Ursa Space Systems Inc. is a geospatial services company that provides aerial and space-based data products to enhance geographic mapping and location-based information. Its offerings include imagery and information products that support market and weather forecasting, agricultural yield improvement, disaster response, and military intelligence. The company is known for its Ursa Global Oil Storage Monitoring solution, which provides insights into global oil storage for hedge funds, commodities traders, banks, and oil companies. Ursa Space Systems serves various sectors, including precision agriculture, business intelligence, weather monitoring, humanitarian relief, civil protection, mapping, and traffic applications. Founded in 2014, the company is headquartered in Ithaca, New York, and leverages radar satellite data to deliver timely reports, fostering transparency in global markets for the finance and energy industries.
Cureatr
Series B in 2021
Cureatr Inc. is a New York-based company that specializes in mobile care coordination solutions for healthcare providers. Founded in 2011, it offers a cloud-based medication management software designed to optimize patient care, particularly focusing on post-discharge medication reconciliation. The platform combines HIPAA-secure text messaging with workflow navigation tools, facilitating communication and coordination among healthcare professionals. Cureatr's software features an inbuilt dashboard that curates and analyzes patients' medication history, enabling providers to respond to real-time events and improve their interactions with patients. By streamlining these processes, Cureatr enhances the overall quality of patient care.
Energy Materials Corporation
Series A in 2021
Energy Materials Corporation develops high-speed, roll-to-roll printing of purebred perovskite solar panels. The company was founded in 2010 and based in Rochester, New York.
Mosaic Microsystems
Seed Round in 2021
Mosaic Microsystems LLC is a microelectronics and photonics packaging company based in Rochester, New York. Founded in 2016, the company specializes in using glass and other thin substrates as a platform material for a variety of applications, including logic, memory, analog and power electronics, photonics, RF, MEMS, and sensor technologies. Mosaic Microsystems aims to enable manufacturers to achieve high-volume production of thin glass components, providing innovative packaging solutions that integrate seamlessly into diverse microelectronics applications.
ENB Therapeutics
Series A in 2021
ENB Therapeutics is a biopharmaceutical company focused on developing small molecule inhibitors aimed at treating melanoma and other cancers. Founded in 2015 and headquartered in New York, the company’s lead product, ENB-001, is a selective endothelin B receptor (ETBR) inhibitor. This innovative therapy has shown promise in preclinical studies to reduce tumor growth and enhance survival rates in cancer models by restoring T-cell infiltration into tumors and inhibiting metastasis. ENB-001 has received Orphan Drug Designation from the FDA, ensuring market exclusivity and strong intellectual property protection. The company is also developing a companion diagnostic to identify patients with over-expressed ETBR pathways, which may allow for expansion into multiple tumor types. By addressing drug resistance commonly seen in cancer patients, ENB Therapeutics aims to establish new standards of care that enhance the effectiveness of existing immunotherapy treatments and improve patient outcomes.
BlocPower
Series A in 2021
BlocPower is an energy technology startup based in Los Angeles, California, focused on creating healthier, greener, and smarter buildings. Founded in 2014 in Brooklyn, New York, by Donnel Baird and Morris Cox, the company specializes in retrofitting urban buildings with advanced energy efficiency technologies and green heating and cooling systems. BlocPower identifies energy-wasting buildings and utilizes a proprietary machine learning platform to determine the most effective retrofits for maximizing energy savings. The company connects various stakeholders, including government agencies, utilities, building owners, and equipment providers, to facilitate these upgrades. With a mission to serve financially underserved communities, BlocPower has completed projects in nearly 1,000 buildings, helping customers save 20–40% on their annual energy bills. By leveraging data and innovative financing, BlocPower aims to reduce carbon emissions and improve health outcomes while addressing the climate crisis.
Mymee
Venture Round in 2021
Mymee, Inc. is a New York-based company that specializes in remote care and support services for individuals with chronic rheumatic and neurological autoimmune diseases. Founded in 2011, Mymee has developed a software-as-a-service health coaching platform that identifies non-obvious triggers for symptoms through personalized analysis of users' daily lives. The platform focuses on dietary and environmental factors that may contribute to disease flares and creates tailored care plans to address these triggers. By combining expert health coaching with behavioral change strategies, Mymee aims to enhance the quality of life for its users. Clinical trials have shown that participants experience significant improvements in various health-related quality of life domains, including fatigue and pain. Through the support of certified health coaches, Mymee empowers individuals to take control of their health and adopt habits that may help reverse their symptoms.
Redpin Therapeutics
Series A in 2021
Redpin Therapeutics is a preclinical stage gene therapy company based in New York, founded in 2017. The company specializes in developing a proprietary chemogenetics platform designed to create targeted cell therapies for intractable diseases of the nervous system. Its innovative approach combines principles from synthetic biology, gene therapy, and conventional pharmacotherapy, utilizing ion channels as neuromodulation tools. This enables selective activation or inhibition of disease-causing neurons, allowing for precise regulation of dysfunctional neuronal circuits while sparing healthy cells. Through its research and development efforts, Redpin Therapeutics aims to provide new treatment options for challenging neurological conditions.
Free Form Fibers
Seed Round in 2020
Free Form Fibers LLC specializes in the development and manufacture of inorganic high-performance fibers using advanced laser-driven chemical vapor deposition technology. The company produces a wide range of filament materials, including silicon carbide, boron carbide, tungsten carbide, and diamond-like carbon, among others. These fibers are designed for various applications such as non-woven filters, catalysts, reinforcement in ceramic and metal matrix composites, and superconducting filaments. Free Form Fibers serves diverse industries, including military and aerospace, automotive, biomedical, and energy, providing solutions that require heat and chemical resistance. Established in 2006 and based in Saratoga Springs, New York, the company focuses on delivering low-cost, high-performance materials for demanding applications.
Artemis
Series A in 2020
Artemis develops a cultivation management platform designed for enterprise greenhouses, indoor farms, and high tunnel farms. This software enables growers to efficiently manage people, plants, processes, and compliance by providing a comprehensive view of facility productivity. Users can track operations and production data remotely through desktops, tablets, or smartphones. The platform allows owners and managers to oversee workflows, register crop batches, address food safety issues, manage personnel, and gain insights to enhance crop productivity. Founded in 2015 and originally named Agrilyst, the company rebranded to Artemis in May 2019 and is headquartered in Brooklyn, New York.
Kinvolved
Seed Round in 2020
Kinvolved, Inc. is a technology company that specializes in mobile and web applications aimed at enhancing communication between schools and families. Its flagship product, KiNVO, facilitates communication regarding attendance, behavior, grades, and other important updates, allowing schools to send messages to entire classrooms or individual parents. The platform also provides valuable data analytics, enabling educators to track attendance and communication trends, flag chronically absent students, and generate reports on student-specific interactions with parents. Kinvolved's solutions target schools and after-school programs, particularly in underserved communities across the United States, with the goal of improving student attendance and reducing chronic absenteeism. Founded in 2012 and based in New York City, Kinvolved combines technology with community engagement to foster better educational outcomes and enhance graduation rates.
Envisagenics
Series A in 2020
Envisagenics, Inc. is a biotechnology company founded in 2013 and headquartered in Huntington, New York. It specializes in the development of a predictive analytics platform aimed at accelerating the discovery of RNA therapeutics. The company leverages advanced artificial intelligence and machine learning algorithms to analyze transcriptomic data, helping researchers identify and validate potential drug targets. Envisagenics' flagship technology, SpliceCore, is a cloud-based platform that utilizes RNA splicing analytics to predict drug targets and biomarkers, addressing the complexities of biomedical data. Given that over 30 million people in the U.S. suffer from genetic diseases or cancers related to RNA splicing errors, the company's mission is to streamline the development of innovative therapeutic solutions. By providing an in-silico RNA therapeutics discovery platform, Envisagenics enhances the efficiency of drug development processes, reducing time, cost, and risk associated with bringing new therapies to market through partnerships with biopharmaceutical companies.
The Cru
Seed Round in 2020
The Cru Inc. is a New York-based company established in 2018 that offers a networking platform specifically designed for women. It provides peer coaching services aimed at facilitating personal and professional development. By creating a supportive environment where like-minded individuals can collaborate, The Cru enables women to connect, share experiences, and help one another achieve their goals. The platform simplifies the networking process, allowing users to focus on their growth and advancement.
Vyv
Series A in 2020
Vyv, formerly known as Vital Vio, Inc., specializes in the design and manufacture of antimicrobial lighting systems under the VioSafe brand. The company produces a range of products, including under cabinet lights, T8 replacement bulbs, and various types of LED luminaires, all engineered to combat infectious pathogens. These innovative lighting solutions are employed in diverse commercial environments such as hospitals, laboratories, food storage facilities, gyms, and schools, among others. Vyv's technology leverages visible light to disrupt the cell membranes of harmful bacteria and viruses, providing a continuous method for infection control. Established in 2012 and based in Troy, New York, the company serves a broad clientele, including notable institutions like Duke University and UCLA Health, and also explores licensing opportunities for consumer and residential applications.
Urban Electric Power
Series B in 2020
Urban Electric Power LLC, founded in 2012 and based in Pearl River, New York, specializes in developing rechargeable zinc anode electricity storage technology. The company offers innovative products such as nickel-zinc (Ni-Zn) flow-assisted battery systems and affordable rechargeable zinc-manganese dioxide (MnO2-Zn) batteries. By transforming traditional alkaline batteries into powerful rechargeable alternatives, Urban Electric Power addresses the shortcomings of existing battery solutions in modern energy infrastructure. The company’s technology leverages earth-abundant materials sourced from allied nations, promoting safe and sustainable supply chains. Urban Electric Power aims to enhance electricity access and reliability, particularly in developing regions where lead-acid batteries are commonly used, thus supporting public health, education, and economic growth through cleaner, renewable energy solutions.
Redpin Therapeutics
Series A in 2020
Redpin Therapeutics is a preclinical stage gene therapy company based in New York, founded in 2017. The company specializes in developing a proprietary chemogenetics platform designed to create targeted cell therapies for intractable diseases of the nervous system. Its innovative approach combines principles from synthetic biology, gene therapy, and conventional pharmacotherapy, utilizing ion channels as neuromodulation tools. This enables selective activation or inhibition of disease-causing neurons, allowing for precise regulation of dysfunctional neuronal circuits while sparing healthy cells. Through its research and development efforts, Redpin Therapeutics aims to provide new treatment options for challenging neurological conditions.
BlocPower
Seed Round in 2020
BlocPower is an energy technology startup based in Los Angeles, California, focused on creating healthier, greener, and smarter buildings. Founded in 2014 in Brooklyn, New York, by Donnel Baird and Morris Cox, the company specializes in retrofitting urban buildings with advanced energy efficiency technologies and green heating and cooling systems. BlocPower identifies energy-wasting buildings and utilizes a proprietary machine learning platform to determine the most effective retrofits for maximizing energy savings. The company connects various stakeholders, including government agencies, utilities, building owners, and equipment providers, to facilitate these upgrades. With a mission to serve financially underserved communities, BlocPower has completed projects in nearly 1,000 buildings, helping customers save 20–40% on their annual energy bills. By leveraging data and innovative financing, BlocPower aims to reduce carbon emissions and improve health outcomes while addressing the climate crisis.
GiveGab
Series A in 2020
GiveGab is a company that specializes in online fundraising services tailored for nonprofit organizations, community foundations, and educational institutions. Founded in 2011 and headquartered in Ithaca, New York, the company offers a comprehensive suite of products designed to facilitate fundraising efforts. Its platform connects nonprofits with volunteers and donors, promoting community giving through donations and peer-to-peer fundraising. By enabling organizations to effectively promote their programs and events, GiveGab fosters relationships among fundraisers, volunteers, and the communities they serve.
Kinvolved
Seed Round in 2020
Kinvolved, Inc. is a technology company that specializes in mobile and web applications aimed at enhancing communication between schools and families. Its flagship product, KiNVO, facilitates communication regarding attendance, behavior, grades, and other important updates, allowing schools to send messages to entire classrooms or individual parents. The platform also provides valuable data analytics, enabling educators to track attendance and communication trends, flag chronically absent students, and generate reports on student-specific interactions with parents. Kinvolved's solutions target schools and after-school programs, particularly in underserved communities across the United States, with the goal of improving student attendance and reducing chronic absenteeism. Founded in 2012 and based in New York City, Kinvolved combines technology with community engagement to foster better educational outcomes and enhance graduation rates.
Ride Health
Series A in 2020
Ride Health LLC is a New York-based company that offers a software-as-a-service platform designed to improve patient access to medical appointments by managing transportation logistics. Founded in 2016, the platform enables healthcare providers to schedule, request, and pay for rides on behalf of patients, addressing transportation barriers that can hinder access to care. It allows coordinators to arrange rides in advance or on-demand, provides real-time updates and reminders to patients, and offers insights into transportation costs and usage. By partnering with healthcare organizations and transportation providers, Ride Health enhances enterprise transportation programs and supports at-risk populations, ensuring that patient needs and preferences are prioritized. This approach aims to improve efficiencies, reduce costs, and ultimately foster better healthcare outcomes.
Soundmind
Seed Round in 2019
Soundmind Intelligence, Inc. is a company based in Brooklyn, New York, that provides a platform featuring conversational A.I. voice assistants specifically designed for senior care providers. Founded in 2018, the company's technology aims to reduce social isolation among older adults by enhancing communication and connectivity. Its voice assistants enable caregivers and administrators to manage accounts for elder residents, offering personalized features such as care plans, calendars, reminders, messaging, and entertainment. By streamlining these functions through voice interaction, Soundmind facilitates improved communication between caregivers, residents, and their families, ultimately supporting better care in senior living environments.
GDI
Series A in 2019
GDI, founded in 2009 and based in Rochester, New York, specializes in the development and manufacture of silicon anodes for lithium-ion batteries. The company focuses on creating patented silicon battery materials that provide superior performance compared to traditional lithium-ion and emerging solid-state batteries. These materials are designed for compatibility with various lithium battery architectures and are engineered for mass production, allowing industries to enhance their product development capabilities. GDI's innovations aim to improve battery performance, particularly in terms of charging times, thereby contributing to a more sustainable and efficient energy future.
Ursa Space Systems
Series B in 2019
Ursa Space Systems Inc. is a geospatial services company that provides aerial and space-based data products to enhance geographic mapping and location-based information. Its offerings include imagery and information products that support market and weather forecasting, agricultural yield improvement, disaster response, and military intelligence. The company is known for its Ursa Global Oil Storage Monitoring solution, which provides insights into global oil storage for hedge funds, commodities traders, banks, and oil companies. Ursa Space Systems serves various sectors, including precision agriculture, business intelligence, weather monitoring, humanitarian relief, civil protection, mapping, and traffic applications. Founded in 2014, the company is headquartered in Ithaca, New York, and leverages radar satellite data to deliver timely reports, fostering transparency in global markets for the finance and energy industries.
Cureatr
Series B in 2019
Cureatr Inc. is a New York-based company that specializes in mobile care coordination solutions for healthcare providers. Founded in 2011, it offers a cloud-based medication management software designed to optimize patient care, particularly focusing on post-discharge medication reconciliation. The platform combines HIPAA-secure text messaging with workflow navigation tools, facilitating communication and coordination among healthcare professionals. Cureatr's software features an inbuilt dashboard that curates and analyzes patients' medication history, enabling providers to respond to real-time events and improve their interactions with patients. By streamlining these processes, Cureatr enhances the overall quality of patient care.
Kangarootime
Series A in 2019
Kangarootime, Inc. is a company that specializes in providing a cloud-based childcare management solution aimed at connecting parents with childcare professionals. Founded in 2015 and headquartered in Buffalo, New York, Kangarootime offers a comprehensive platform that includes features such as revenue cycle management, mobile and laptop accessibility, enrollment processes, and automated check-in and check-out functionalities. Its services enhance communication and compliance for childcare centers by enabling features like messaging, picture sharing, and employee management. By streamlining operations and improving the connection between care centers and families, Kangarootime empowers childcare providers to scale their operations and adapt in a digital environment.
GiveGab
Series A in 2019
GiveGab is a company that specializes in online fundraising services tailored for nonprofit organizations, community foundations, and educational institutions. Founded in 2011 and headquartered in Ithaca, New York, the company offers a comprehensive suite of products designed to facilitate fundraising efforts. Its platform connects nonprofits with volunteers and donors, promoting community giving through donations and peer-to-peer fundraising. By enabling organizations to effectively promote their programs and events, GiveGab fosters relationships among fundraisers, volunteers, and the communities they serve.
Urban Electric Power
Series B in 2019
Urban Electric Power LLC, founded in 2012 and based in Pearl River, New York, specializes in developing rechargeable zinc anode electricity storage technology. The company offers innovative products such as nickel-zinc (Ni-Zn) flow-assisted battery systems and affordable rechargeable zinc-manganese dioxide (MnO2-Zn) batteries. By transforming traditional alkaline batteries into powerful rechargeable alternatives, Urban Electric Power addresses the shortcomings of existing battery solutions in modern energy infrastructure. The company’s technology leverages earth-abundant materials sourced from allied nations, promoting safe and sustainable supply chains. Urban Electric Power aims to enhance electricity access and reliability, particularly in developing regions where lead-acid batteries are commonly used, thus supporting public health, education, and economic growth through cleaner, renewable energy solutions.
Concertio
Seed Round in 2019
Concertio Inc. specializes in artificial intelligence-driven system performance optimization software, enabling enterprises to enhance computing efficiency while minimizing infrastructure costs. Founded in 2016 and headquartered in New York, the company offers the Concertio Optimizer, which continuously monitors the interactions between applications and systems, automating parameter tuning throughout development and deployment. Its tools, including Optimizer Studio and Optimizer Runtime, cater to performance engineers and IT professionals by providing an optimization toolkit and a dynamic optimization framework that improve the performance of systems and components in real-time. Concertio's solutions are utilized by prominent industry players such as Intel and Marvell, transforming general-purpose systems into specialized, high-performance configurations tailored to specific workloads.
Artemis
Series A in 2019
Artemis develops a cultivation management platform designed for enterprise greenhouses, indoor farms, and high tunnel farms. This software enables growers to efficiently manage people, plants, processes, and compliance by providing a comprehensive view of facility productivity. Users can track operations and production data remotely through desktops, tablets, or smartphones. The platform allows owners and managers to oversee workflows, register crop batches, address food safety issues, manage personnel, and gain insights to enhance crop productivity. Founded in 2015 and originally named Agrilyst, the company rebranded to Artemis in May 2019 and is headquartered in Brooklyn, New York.
Vyv
Seed Round in 2019
Vyv, formerly known as Vital Vio, Inc., specializes in the design and manufacture of antimicrobial lighting systems under the VioSafe brand. The company produces a range of products, including under cabinet lights, T8 replacement bulbs, and various types of LED luminaires, all engineered to combat infectious pathogens. These innovative lighting solutions are employed in diverse commercial environments such as hospitals, laboratories, food storage facilities, gyms, and schools, among others. Vyv's technology leverages visible light to disrupt the cell membranes of harmful bacteria and viruses, providing a continuous method for infection control. Established in 2012 and based in Troy, New York, the company serves a broad clientele, including notable institutions like Duke University and UCLA Health, and also explores licensing opportunities for consumer and residential applications.
Unite Us
Series B in 2019
Unite Us is a veteran-led technology company founded in 2013 in New York, specializing in creating coordinated care networks that connect health and social service providers. The company develops a platform that enables providers to send and receive secure referrals, track individuals' health journeys, and report on outcomes across a variety of services. By integrating social determinants of health into patient care, Unite Us facilitates a cohesive and collaborative ecosystem that enhances the ability of communities to deliver services effectively. This innovative approach moves beyond traditional resource directories, allowing systems to measure impact and improve health outcomes on a larger scale.
Loliware
Seed Round in 2019
Loliware LLC is a company based in Beacon, New York, that specializes in manufacturing biodegradable and edible disposable cups and other single-use products aimed at eliminating plastic waste. Founded in 2015, the company has developed an innovative range of products made from bio-renewable seaweed, which are designed to be compostable and environmentally friendly. Loliware's mission is to promote a plastic-free, decarbonized future by offering alternatives that are not only compostable but also have a lower carbon footprint compared to traditional plastics. Their initial product, an ocean-safe and tree-free drinking straw, has received accolades for its potential to set new industry standards. The company is actively working on expanding its product line, with plans to introduce six new items by the end of 2023, all of which aim to provide sustainable solutions for chefs, restaurant chains, and eco-conscious businesses looking to reduce their environmental impact.
Kinvolved
Seed Round in 2018
Kinvolved, Inc. is a technology company that specializes in mobile and web applications aimed at enhancing communication between schools and families. Its flagship product, KiNVO, facilitates communication regarding attendance, behavior, grades, and other important updates, allowing schools to send messages to entire classrooms or individual parents. The platform also provides valuable data analytics, enabling educators to track attendance and communication trends, flag chronically absent students, and generate reports on student-specific interactions with parents. Kinvolved's solutions target schools and after-school programs, particularly in underserved communities across the United States, with the goal of improving student attendance and reducing chronic absenteeism. Founded in 2012 and based in New York City, Kinvolved combines technology with community engagement to foster better educational outcomes and enhance graduation rates.
ENB Therapeutics
Series A in 2018
ENB Therapeutics is a biopharmaceutical company focused on developing small molecule inhibitors aimed at treating melanoma and other cancers. Founded in 2015 and headquartered in New York, the company’s lead product, ENB-001, is a selective endothelin B receptor (ETBR) inhibitor. This innovative therapy has shown promise in preclinical studies to reduce tumor growth and enhance survival rates in cancer models by restoring T-cell infiltration into tumors and inhibiting metastasis. ENB-001 has received Orphan Drug Designation from the FDA, ensuring market exclusivity and strong intellectual property protection. The company is also developing a companion diagnostic to identify patients with over-expressed ETBR pathways, which may allow for expansion into multiple tumor types. By addressing drug resistance commonly seen in cancer patients, ENB Therapeutics aims to establish new standards of care that enhance the effectiveness of existing immunotherapy treatments and improve patient outcomes.
ENB Therapeutics
Seed Round in 2018
ENB Therapeutics is a biopharmaceutical company focused on developing small molecule inhibitors aimed at treating melanoma and other cancers. Founded in 2015 and headquartered in New York, the company’s lead product, ENB-001, is a selective endothelin B receptor (ETBR) inhibitor. This innovative therapy has shown promise in preclinical studies to reduce tumor growth and enhance survival rates in cancer models by restoring T-cell infiltration into tumors and inhibiting metastasis. ENB-001 has received Orphan Drug Designation from the FDA, ensuring market exclusivity and strong intellectual property protection. The company is also developing a companion diagnostic to identify patients with over-expressed ETBR pathways, which may allow for expansion into multiple tumor types. By addressing drug resistance commonly seen in cancer patients, ENB Therapeutics aims to establish new standards of care that enhance the effectiveness of existing immunotherapy treatments and improve patient outcomes.
PostProcess
Series A in 2018
PostProcess Technologies Inc. specializes in automated solutions for post-printing processes in additive manufacturing. Founded in 2014 and headquartered in Buffalo, New York, with an additional location in Sophia-Antipolis, France, the company develops a combination of software, hardware, and chemistry to streamline support removal and surface finishing for 3D printed parts. Its offerings include automated systems for resin removal and surface finishing, such as submersion and spray systems, as well as a range of consumables and hybrid products tailored for various industries, including aerospace, defense, automotive, consumer goods, dental, and medical sectors. By addressing the challenges of post-printing, PostProcess Technologies enhances production efficiency and precision across different 3D printing technologies.
GiveGab
Series A in 2018
GiveGab is a company that specializes in online fundraising services tailored for nonprofit organizations, community foundations, and educational institutions. Founded in 2011 and headquartered in Ithaca, New York, the company offers a comprehensive suite of products designed to facilitate fundraising efforts. Its platform connects nonprofits with volunteers and donors, promoting community giving through donations and peer-to-peer fundraising. By enabling organizations to effectively promote their programs and events, GiveGab fosters relationships among fundraisers, volunteers, and the communities they serve.
Cureatr
Series B in 2018
Cureatr Inc. is a New York-based company that specializes in mobile care coordination solutions for healthcare providers. Founded in 2011, it offers a cloud-based medication management software designed to optimize patient care, particularly focusing on post-discharge medication reconciliation. The platform combines HIPAA-secure text messaging with workflow navigation tools, facilitating communication and coordination among healthcare professionals. Cureatr's software features an inbuilt dashboard that curates and analyzes patients' medication history, enabling providers to respond to real-time events and improve their interactions with patients. By streamlining these processes, Cureatr enhances the overall quality of patient care.
Artemis
Venture Round in 2018
Artemis develops a cultivation management platform designed for enterprise greenhouses, indoor farms, and high tunnel farms. This software enables growers to efficiently manage people, plants, processes, and compliance by providing a comprehensive view of facility productivity. Users can track operations and production data remotely through desktops, tablets, or smartphones. The platform allows owners and managers to oversee workflows, register crop batches, address food safety issues, manage personnel, and gain insights to enhance crop productivity. Founded in 2015 and originally named Agrilyst, the company rebranded to Artemis in May 2019 and is headquartered in Brooklyn, New York.
Cureatr
Venture Round in 2018
Cureatr Inc. is a New York-based company that specializes in mobile care coordination solutions for healthcare providers. Founded in 2011, it offers a cloud-based medication management software designed to optimize patient care, particularly focusing on post-discharge medication reconciliation. The platform combines HIPAA-secure text messaging with workflow navigation tools, facilitating communication and coordination among healthcare professionals. Cureatr's software features an inbuilt dashboard that curates and analyzes patients' medication history, enabling providers to respond to real-time events and improve their interactions with patients. By streamlining these processes, Cureatr enhances the overall quality of patient care.
ChannelEyes
Seed Round in 2018
ChannelEyes Corporation, founded in 2011 and based in Troy, New York, specializes in developing a channel acceleration platform aimed at enhancing the connection between vendors, suppliers, and their channel partners. The company's flagship product, ChannelCandy, is a mobile application designed to deliver essential information such as company news, product details, incentives, and educational resources directly to partners, thereby fostering engagement and sales enablement among agents, dealers, resellers, and retail sales teams. Additionally, ChannelEyes offers OPTYX, an innovative indirect sales workflow tool that utilizes predictive analytics and big data to optimize sales processes. Recognized for its cutting-edge technology, ChannelEyes has received accolades including being named a Cool Vendor by Gartner and recognized as one of the fastest growing companies in New York’s Capital Region.
Loliware
Seed Round in 2018
Loliware LLC is a company based in Beacon, New York, that specializes in manufacturing biodegradable and edible disposable cups and other single-use products aimed at eliminating plastic waste. Founded in 2015, the company has developed an innovative range of products made from bio-renewable seaweed, which are designed to be compostable and environmentally friendly. Loliware's mission is to promote a plastic-free, decarbonized future by offering alternatives that are not only compostable but also have a lower carbon footprint compared to traditional plastics. Their initial product, an ocean-safe and tree-free drinking straw, has received accolades for its potential to set new industry standards. The company is actively working on expanding its product line, with plans to introduce six new items by the end of 2023, all of which aim to provide sustainable solutions for chefs, restaurant chains, and eco-conscious businesses looking to reduce their environmental impact.
GDI
Seed Round in 2018
GDI, founded in 2009 and based in Rochester, New York, specializes in the development and manufacture of silicon anodes for lithium-ion batteries. The company focuses on creating patented silicon battery materials that provide superior performance compared to traditional lithium-ion and emerging solid-state batteries. These materials are designed for compatibility with various lithium battery architectures and are engineered for mass production, allowing industries to enhance their product development capabilities. GDI's innovations aim to improve battery performance, particularly in terms of charging times, thereby contributing to a more sustainable and efficient energy future.
GiveGab
Series A in 2018
GiveGab is a company that specializes in online fundraising services tailored for nonprofit organizations, community foundations, and educational institutions. Founded in 2011 and headquartered in Ithaca, New York, the company offers a comprehensive suite of products designed to facilitate fundraising efforts. Its platform connects nonprofits with volunteers and donors, promoting community giving through donations and peer-to-peer fundraising. By enabling organizations to effectively promote their programs and events, GiveGab fosters relationships among fundraisers, volunteers, and the communities they serve.
Redpin Therapeutics
Venture Round in 2018
Redpin Therapeutics is a preclinical stage gene therapy company based in New York, founded in 2017. The company specializes in developing a proprietary chemogenetics platform designed to create targeted cell therapies for intractable diseases of the nervous system. Its innovative approach combines principles from synthetic biology, gene therapy, and conventional pharmacotherapy, utilizing ion channels as neuromodulation tools. This enables selective activation or inhibition of disease-causing neurons, allowing for precise regulation of dysfunctional neuronal circuits while sparing healthy cells. Through its research and development efforts, Redpin Therapeutics aims to provide new treatment options for challenging neurological conditions.
Quentis Therapeutics
Series A in 2018
Quentis Therapeutics, Inc. is a biotechnology company based in New York, founded in 2016. The company specializes in developing immunotherapies that target endoplasmic reticulum (ER) stress response pathways within the tumor microenvironment. By addressing ER stress, Quentis aims to enhance the immune system's capacity to combat cancer, providing patients with innovative treatment options. Its therapeutic approach focuses on awakening anti-tumor immunity, thereby potentially improving outcomes for individuals facing various forms of cancer.
Forkhead BioTherapeutics
Seed Round in 2018
Forkhead BioTherapeutics Inc is focused on developing innovative oral therapies for insulin-dependent diabetes. Based in New York, the company has created Foxin, an oral agent designed to target and delete the FOXO1 protein, which plays a crucial role in regulating insulin production and glucose metabolism. Founded in 2017, Forkhead Bio aims to harness the natural processes of cell conversion and regeneration to create transformative treatments that enhance the quality of life for patients with diabetes.
Vyv
Venture Round in 2018
Vyv, formerly known as Vital Vio, Inc., specializes in the design and manufacture of antimicrobial lighting systems under the VioSafe brand. The company produces a range of products, including under cabinet lights, T8 replacement bulbs, and various types of LED luminaires, all engineered to combat infectious pathogens. These innovative lighting solutions are employed in diverse commercial environments such as hospitals, laboratories, food storage facilities, gyms, and schools, among others. Vyv's technology leverages visible light to disrupt the cell membranes of harmful bacteria and viruses, providing a continuous method for infection control. Established in 2012 and based in Troy, New York, the company serves a broad clientele, including notable institutions like Duke University and UCLA Health, and also explores licensing opportunities for consumer and residential applications.
Unite Us
Series A in 2017
Unite Us is a veteran-led technology company founded in 2013 in New York, specializing in creating coordinated care networks that connect health and social service providers. The company develops a platform that enables providers to send and receive secure referrals, track individuals' health journeys, and report on outcomes across a variety of services. By integrating social determinants of health into patient care, Unite Us facilitates a cohesive and collaborative ecosystem that enhances the ability of communities to deliver services effectively. This innovative approach moves beyond traditional resource directories, allowing systems to measure impact and improve health outcomes on a larger scale.
PostProcess
Seed Round in 2017
PostProcess Technologies Inc. specializes in automated solutions for post-printing processes in additive manufacturing. Founded in 2014 and headquartered in Buffalo, New York, with an additional location in Sophia-Antipolis, France, the company develops a combination of software, hardware, and chemistry to streamline support removal and surface finishing for 3D printed parts. Its offerings include automated systems for resin removal and surface finishing, such as submersion and spray systems, as well as a range of consumables and hybrid products tailored for various industries, including aerospace, defense, automotive, consumer goods, dental, and medical sectors. By addressing the challenges of post-printing, PostProcess Technologies enhances production efficiency and precision across different 3D printing technologies.
ChannelEyes
Seed Round in 2017
ChannelEyes Corporation, founded in 2011 and based in Troy, New York, specializes in developing a channel acceleration platform aimed at enhancing the connection between vendors, suppliers, and their channel partners. The company's flagship product, ChannelCandy, is a mobile application designed to deliver essential information such as company news, product details, incentives, and educational resources directly to partners, thereby fostering engagement and sales enablement among agents, dealers, resellers, and retail sales teams. Additionally, ChannelEyes offers OPTYX, an innovative indirect sales workflow tool that utilizes predictive analytics and big data to optimize sales processes. Recognized for its cutting-edge technology, ChannelEyes has received accolades including being named a Cool Vendor by Gartner and recognized as one of the fastest growing companies in New York’s Capital Region.
GDI
Seed Round in 2016
GDI, founded in 2009 and based in Rochester, New York, specializes in the development and manufacture of silicon anodes for lithium-ion batteries. The company focuses on creating patented silicon battery materials that provide superior performance compared to traditional lithium-ion and emerging solid-state batteries. These materials are designed for compatibility with various lithium battery architectures and are engineered for mass production, allowing industries to enhance their product development capabilities. GDI's innovations aim to improve battery performance, particularly in terms of charging times, thereby contributing to a more sustainable and efficient energy future.
ChannelEyes
Seed Round in 2016
ChannelEyes Corporation, founded in 2011 and based in Troy, New York, specializes in developing a channel acceleration platform aimed at enhancing the connection between vendors, suppliers, and their channel partners. The company's flagship product, ChannelCandy, is a mobile application designed to deliver essential information such as company news, product details, incentives, and educational resources directly to partners, thereby fostering engagement and sales enablement among agents, dealers, resellers, and retail sales teams. Additionally, ChannelEyes offers OPTYX, an innovative indirect sales workflow tool that utilizes predictive analytics and big data to optimize sales processes. Recognized for its cutting-edge technology, ChannelEyes has received accolades including being named a Cool Vendor by Gartner and recognized as one of the fastest growing companies in New York’s Capital Region.
Artemis
Seed Round in 2016
Artemis develops a cultivation management platform designed for enterprise greenhouses, indoor farms, and high tunnel farms. This software enables growers to efficiently manage people, plants, processes, and compliance by providing a comprehensive view of facility productivity. Users can track operations and production data remotely through desktops, tablets, or smartphones. The platform allows owners and managers to oversee workflows, register crop batches, address food safety issues, manage personnel, and gain insights to enhance crop productivity. Founded in 2015 and originally named Agrilyst, the company rebranded to Artemis in May 2019 and is headquartered in Brooklyn, New York.
ChannelEyes
Venture Round in 2016
ChannelEyes Corporation, founded in 2011 and based in Troy, New York, specializes in developing a channel acceleration platform aimed at enhancing the connection between vendors, suppliers, and their channel partners. The company's flagship product, ChannelCandy, is a mobile application designed to deliver essential information such as company news, product details, incentives, and educational resources directly to partners, thereby fostering engagement and sales enablement among agents, dealers, resellers, and retail sales teams. Additionally, ChannelEyes offers OPTYX, an innovative indirect sales workflow tool that utilizes predictive analytics and big data to optimize sales processes. Recognized for its cutting-edge technology, ChannelEyes has received accolades including being named a Cool Vendor by Gartner and recognized as one of the fastest growing companies in New York’s Capital Region.
Unite Us
Series A in 2015
Unite Us is a veteran-led technology company founded in 2013 in New York, specializing in creating coordinated care networks that connect health and social service providers. The company develops a platform that enables providers to send and receive secure referrals, track individuals' health journeys, and report on outcomes across a variety of services. By integrating social determinants of health into patient care, Unite Us facilitates a cohesive and collaborative ecosystem that enhances the ability of communities to deliver services effectively. This innovative approach moves beyond traditional resource directories, allowing systems to measure impact and improve health outcomes on a larger scale.
Cureatr
Series B in 2015
Cureatr Inc. is a New York-based company that specializes in mobile care coordination solutions for healthcare providers. Founded in 2011, it offers a cloud-based medication management software designed to optimize patient care, particularly focusing on post-discharge medication reconciliation. The platform combines HIPAA-secure text messaging with workflow navigation tools, facilitating communication and coordination among healthcare professionals. Cureatr's software features an inbuilt dashboard that curates and analyzes patients' medication history, enabling providers to respond to real-time events and improve their interactions with patients. By streamlining these processes, Cureatr enhances the overall quality of patient care.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.